Clinical Trial Update: Adjuvant Temozolomide ± 5-Aminolevulinic Acid + Low Intensity Diffuse Ultrasound Sonodynamic Therapy System for Newly Diagnosed Glioblastoma [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update for newly diagnosed glioblastoma evaluating adjuvant temozolomide with optional 5-aminolevulinic acid and low-intensity diffuse ul…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glioblastoma

Drugs mentioned

• 5-ALA (5-aminolevulinic acid)
• Temodar (Temozolomide)

Snippet

Sponsor: Alpheus Medical, Inc. | Conditions: Glioblastoma, GBM | Phase 2 | Status: RECRUITING